Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777528 · ClinicalTrials.gov registry record · NA
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
A NA study of Aortic Aneurysm, Thoracic and Aorta; Lesion, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 20
- Study locations
NCT02777528 is a NA study of Aortic Aneurysm, Thoracic and Aorta; Lesion that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 79 participants, below the 226-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (65% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT02777528, a NA study of Aortic Aneurysm, Thoracic and Aorta; Lesion, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.
Conditions Studied
Interventions
- DEVICE GORE® TAG® Thoracic Branch Endoprosthesis
- PROCEDURE Revascularization Procedure
Study Locations (20)
California
- Keck Medical Center of USC - Los Angeles
- Cedar-Sinai Medical Center - Los Angeles
- Leland Stanford Junior University - Stanford
Florida
- University of Florida-Gainesville - Gainesville
- University of South Florida - Tampa
North Carolina
- Carolinas HealthCare Systems - Charlotte
- Duke University Medical Center - Durham
Connecticut
- Hartford Hospital - Hartford
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Georgia
- Emory University - Atlanta
Illinois
- Northwesten University - Chicago
Indiana
- St. Vincent Medical Group, Inc. - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-08 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02777528
The ClinicalTrials.gov registry entry for NCT02777528 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (65% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aortic Aneurysm, Thoracic appearing as the primary indexed condition, and to 2 interventions - of which GORE® TAG® Thoracic Branch Endoprosthesis is the first listed.
NCT02777528 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02777528 about?
NCT02777528 is a clinical study titled "Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1". The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.
What is the current status of trial NCT02777528?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 79 participants. The study started on 2016-08. Estimated completion is 2028-03.
What conditions does trial NCT02777528 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Thoracic, Aorta; Lesion.
What interventions are being tested in trial NCT02777528?
The interventions under investigation include: GORE® TAG® Thoracic Branch Endoprosthesis (DEVICE), Revascularization Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT02777528?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02777528 being conducted?
This trial has 20 study locations across California, Connecticut, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Thoracic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
ACTIVE NOT RECRUITING · NA
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
ACTIVE NOT RECRUITING · NA
-
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.